Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation
View Full Paper
Ask AI
Bookmark
Share
Key result
Amiodarone is the most effective antiarrhythmic for maintaining sinus rhythm but has significant adverse effects, while dronedarone reduces cardiovascular hospitalizations but increases mortality in decompensated heart failure.
Why the study?
Does antiarrhythmic drug therapy improve clinical outcomes in patients with atrial fibrillation?
Population
Patients with atrial fibrillation
Comparison
Antiarrhythmic drug therapy vs Rate control strategy or placebo
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports individualized AAD selection in AF with toxicity monitoring; leaves open safer long-term rhythm-control options.
Structured PICO
Does antiarrhythmic drug therapy improve clinical outcomes in patients with atrial fibrillation?
P
Population
A narrative review of clinical trials and meta-analyses evaluating the efficacy and safety of antiarrhythmic drug therapies for the management of atrial fibrillation.
I
Intervention
Antiarrhythmic drug therapy (rhythm control strategy, including amiodarone and dronedarone)
C
Comparator
Rate control strategy or placebo
O
Outcome
Mortality, cardiovascular hospitalizations, and maintenance of sinus rhythm
While amiodarone is the most efficacious drug for maintaining sinus rhythm, it lacks a survival benefit; dronedarone reduces cardiovascular hospitalizations in non-permanent AF but is contraindicated in decompensated heart failure.
Limitations
- Rhythm control strategies have generally failed to demonstrate a survival benefit over rate control
- Amiodarone is associated with high rates of serious adverse events
- Dronedarone is contraindicated in patients with recently decompensated heart failure due to increased mortality
Cite This Study
Stefan H. Hohnloser (2012) conducted a review in Atrial fibrillation. Antiarrhythmic drugs (e.g., amiodarone, dronedarone) vs. Rate control or placebo was evaluated. Amiodarone is the most effective antiarrhythmic for maintaining sinus rhythm but has significant adverse effects, while dronedarone reduces cardiovascular hospitalizations but increases mortality in decompensated heart failure.
Topics
View Full Paper
Ask AI
Bookmark
Share